<DOC>
	<DOCNO>NCT00090246</DOCNO>
	<brief_summary>The purpose study assess safety efficacy 2 dos approve drug new indication prevention postoperative nausea vomit patient receive general anesthesia open abdominal surgery require overnight hospital stay .</brief_summary>
	<brief_title>2 Doses Approved Drug Being Studied New Indication Prevention Postoperative Nausea Vomiting ( 0869-091 )</brief_title>
	<detailed_description>The duration treatment 4 week .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Patient least 18 year age . Patient schedule undergo open abdominal surgery require overnight hospital stay ( 24hour hospital stay end surgery ) . Patient schedule receive general anesthesia . Patient schedule receive postoperative opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>